Postural orthostatic tachycardia syndrome: when dysautonomia misleads: a mechanistic argument for compensatory orthostatic tachycardia, 2026, Chopra

Mij

Senior Member (Voting Rights)
Abstract

Postural orthostatic tachycardia syndrome (POTS) is defined by chronic orthostatic intolerance accompanied by an excessive increment in sinus heart rate on standing in the absence of significant orthostatic hypotension. Contemporary reviews and consensus statements appropriately frame POTS as involving autonomic regulation. Yet the bedside phenotype most often observed-marked tachycardia with preserved blood pressure-also supports a hemodynamic interpretation: an intact baroreflex driving tachycardia to defend cardiac output and cerebral perfusion when effective stroke volume or venous return is reduced. This narrative, hypothesis-driven review argues that the umbrella label ‘dysautonomia’ is frequently applied imprecisely in POTS and is often interpreted (by clinicians and patients) as autonomic failure.

In many patients, the dominant physiology is not autonomic failure but compensatory activation in response to orthostatic stressors such as low central blood volume, venous pooling, impaired vasoconstriction, or deconditioning. When the label is over-interpreted, management can drift toward reflexive heart-rate suppression rather than mechanism-directed evaluation and treatment of the orthostatic stressor.

We propose a pragmatic, cardiology-facing framework that (1) distinguishes compensatory orthostatic tachycardia from primary autonomic failure (neurogenic orthostatic hypotension), and (2) prioritizes mechanistic phenotyping within POTS (low-preload/pooling dominant, neuropathic, hyperadrenergic, immune-associated, and secondary structural/CSF-pressure contributors). This reframing does not minimize the severity of POTS; rather, it supports clearer counseling and more targeted therapy by treating tachycardia as a signal of orthostatic stress and asking what is driving it.

Highlights
  • POTS is defined by orthostatic tachycardia with symptoms and without significant orthostatic hypotension; it is not synonymous with autonomic failure.
  • Tachycardia with preserved BP is compatible with an intact baroreflex compensating for reduced stroke volume/venous return or impaired peripheral vasoconstriction.
  • The term ‘dysautonomia’ is often over-interpreted as ‘autonomic failure,’ or ‘dysfunction of the autonomic nervous system’ which can misdirect counseling and treatment; precision matters.
  • Mechanistic phenotyping enables targeted therapy and avoids reflexive heart-rate suppression in low-preload/pooling-dominant presentations.
Study
 
Yet the bedside phenotype most often observed-marked tachycardia with preserved blood pressure-also supports a hemodynamic interpretation: an intact baroreflex driving tachycardia to defend cardiac output and cerebral perfusion when effective stroke volume or venous return is reduced.

This is more how POTS felt to me. Like a compensation for some undefinable problem.
 
  • Like
Reactions: Mij
They are right that POTS has been a mess for a long time, but I’m not sure they’ve looked properly at the literature with regards to treatments:

7 Implications for cardiology practice​

Confirm diagnostic criteria and exclude mimics (anemia, thyroid disease, dehydration, medication effects, inappropriate sinus tachycardia).

Prioritize nonpharmacologic therapies that improve preload and venous return (salt/fluid loading, lower-body and abdominal compression, graded recumbent exercise reconditioning) as first-line management.
Don’t think any of those have demonstrated any benefit in controlled studies
Select pharmacologic therapy based on phenotype: rate control (low-dose beta-blocker or ivabradine) may help some; vasoconstrictors and volume expanders may be prioritized in pooling/hypovolemia; centrally acting sympatholytics may be considered selectively in hyperadrenergic phenotypes.
Maintain vigilance for secondary causes (connective tissue disorders, immune-mediated disease, and selected structural/CSF-pressure syndromes) when symptoms are atypical or refractory.
 
Back
Top Bottom